DE2061515A1 - 2,5 disubstituierte Imidazole und Ver fahren zur Herstellung derselben - Google Patents

2,5 disubstituierte Imidazole und Ver fahren zur Herstellung derselben

Info

Publication number
DE2061515A1
DE2061515A1 DE19702061515 DE2061515A DE2061515A1 DE 2061515 A1 DE2061515 A1 DE 2061515A1 DE 19702061515 DE19702061515 DE 19702061515 DE 2061515 A DE2061515 A DE 2061515A DE 2061515 A1 DE2061515 A1 DE 2061515A1
Authority
DE
Germany
Prior art keywords
lower alkyl
aryl
compound
substituted
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702061515
Other languages
German (de)
English (en)
Inventor
John James Lansdale Novello Frederick Charles Berwyn Pa Baldwin (V St A)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2061515A1 publication Critical patent/DE2061515A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/93—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by halogen atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19702061515 1969-12-15 1970-12-14 2,5 disubstituierte Imidazole und Ver fahren zur Herstellung derselben Pending DE2061515A1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US88536269A 1969-12-15 1969-12-15
US26501572A 1972-06-21 1972-06-21
US00265016A US3818014A (en) 1969-12-15 1972-06-21 2-quinolyl-4(5)-trifluoromethylimidazoles
US45610274A 1974-03-29 1974-03-29
US61090375A 1975-09-05 1975-09-05
US05/610,904 US4032522A (en) 1969-12-15 1975-09-05 2-pyrazinyl-trifluoromethylimidazoles and a method for their preparation

Publications (1)

Publication Number Publication Date
DE2061515A1 true DE2061515A1 (de) 1971-06-24

Family

ID=27559450

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19702061515 Pending DE2061515A1 (de) 1969-12-15 1970-12-14 2,5 disubstituierte Imidazole und Ver fahren zur Herstellung derselben
DE2061489A Expired DE2061489C2 (de) 1969-12-15 1970-12-14 Anti-Gichtmittel und anti-hyperurikämische Mittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2061489A Expired DE2061489C2 (de) 1969-12-15 1970-12-14 Anti-Gichtmittel und anti-hyperurikämische Mittel

Country Status (10)

Country Link
US (4) US3786061A (US20100223739A1-20100909-C00005.png)
AT (1) AT300788B (US20100223739A1-20100909-C00005.png)
BE (1) BE760289A (US20100223739A1-20100909-C00005.png)
CA (1) CA945161A (US20100223739A1-20100909-C00005.png)
CH (1) CH566994A5 (US20100223739A1-20100909-C00005.png)
DE (2) DE2061515A1 (US20100223739A1-20100909-C00005.png)
FR (1) FR2081360B1 (US20100223739A1-20100909-C00005.png)
GB (1) GB1301754A (US20100223739A1-20100909-C00005.png)
NL (1) NL7017486A (US20100223739A1-20100909-C00005.png)
SE (1) SE388855B (US20100223739A1-20100909-C00005.png)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2155558A1 (US20100223739A1-20100909-C00005.png) * 1970-11-16 1972-06-29
US4058614A (en) * 1973-12-04 1977-11-15 Merck & Co., Inc. Substituted imidazole compounds and therapeutic compositions therewith
WO2000018763A2 (en) * 1998-09-29 2000-04-06 Neurogen Corporation 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US6288230B1 (en) 1998-09-29 2001-09-11 Neurogen Corporation 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7017486A (US20100223739A1-20100909-C00005.png) * 1969-12-15 1971-06-17
GB1481512A (en) * 1973-07-12 1977-08-03 Lucas Electrical Ltd Radiation-sensitive switching circuits
DE2414280C2 (de) * 1974-03-25 1981-12-17 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 1-Methyl-5-nitroimidazolen
US4853383A (en) * 1975-03-03 1989-08-01 Merck & Co., Inc. β-blocking substituted imidazoles
US4199580A (en) * 1975-03-03 1980-04-22 Merck & Co., Inc. 3-Amino-2-or-propoxy-tetrahydronaphthyl or indanyl-substituted imidazoles and use
US4134983A (en) * 1975-03-03 1979-01-16 Merck & Co., Inc. 3-amino-2-or-propoxyaryl substituted imidazoles
US4179512A (en) * 1977-03-01 1979-12-18 Merck & Co., Inc. 4-Substituted-2-arylimidazoles
US4314844A (en) * 1979-01-11 1982-02-09 Rohm And Haas Company Herbicidal substituted imidazoles
US4281005A (en) * 1979-03-05 1981-07-28 Merck & Co., Inc. Novel 2-pyridylimidazole compounds
DE3121736C2 (de) * 1980-06-02 1994-04-07 American Cyanamid Co 2-(2-Imidazolin-2-yl)-pyridine und -chinoline, Verfahren und Zwischenstufen zur Herstellung derselben und Verwendung derselben als herbizide Wirkstoffe
IL62794A0 (en) * 1980-06-02 1981-07-31 American Cyanamid Co Substituted nicotinic acid esters and salts thereof and their use as herbicidal agents
US4315021A (en) * 1980-12-03 1982-02-09 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4499097A (en) * 1983-03-10 1985-02-12 American Cyanamid Company 2-(Pyridyl)imidazolyl ketones
US4602093A (en) * 1984-02-08 1986-07-22 Merck & Co., Inc. Novel substituted imidazoles, their preparation and use
FR2576308B1 (fr) * 1985-01-18 1987-02-20 Synthelabo Derives de tetrahydroquinoleine, leur preparation et leur application en therapeutique
GB8705183D0 (en) * 1987-03-05 1987-04-08 May & Baker Ltd Compositions of matter
US4914207A (en) * 1989-05-09 1990-04-03 Pfizer Inc. Arylthiazolylimidazoles
FR2649999B1 (fr) * 1989-07-21 1991-09-20 Payen Cie L Procede et machine pour la fabrication en continu d'un fil elastique a base d'elasthane
YU47834B (sr) * 1989-08-10 1996-01-09 Schering Agrochemical Limited Azolni pesticid
US5189053A (en) * 1989-08-10 1993-02-23 Schering Agrochemicals Limited Imidazol(in)e substituted haloarylpyrazole pesticides
JP3393891B2 (ja) * 1992-08-18 2003-04-07 塩野義製薬株式会社 イミダゾール類の製造方法
WO1995033730A1 (fr) * 1994-06-09 1995-12-14 Nippon Soda Co., Ltd. Derive d'imidazole, procede de production et herbicide
GB9715814D0 (en) * 1997-07-25 1997-10-01 Black James Foundation Histamine H3 receptor ligands
GB2344588B (en) * 1997-07-25 2001-11-14 Black James Foundation 1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands
EP1044002A4 (en) 1997-11-07 2003-05-02 Univ Johns Hopkins METHODS FOR THE TREATMENT OF HEART CONTRACTILITY
DE60137635D1 (de) * 2000-06-28 2009-03-26 Merck & Co Inc Verwendung von allopurinol zur behandlung von bluthochdruck
CN101597262A (zh) * 2002-03-05 2009-12-09 特兰斯泰克制药公司 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物
JP2007503469A (ja) * 2003-05-20 2007-02-22 トランス　テック　ファーマ，インコーポレイテッド アミロイド症およびそれに関連した疾患を改善するための作用物質としてのｒａｇｅアンタゴニスト
JPWO2007043401A1 (ja) * 2005-10-07 2009-04-16 キッセイ薬品工業株式会社 含窒素複素環化合物およびそれを含有する医薬組成物
TWI517850B (zh) 2009-09-30 2016-01-21 Ｖｔｖ治療有限責任公司 經取代之咪唑衍生物及其使用方法
HU1000676D0 (en) 2010-12-17 2011-02-28 Pharmahungary 2000 Kft Inhibitors of matrix metalloproteinase, pharmaceutical compositions thereof and use of them for preventing and treating diseases where the activation of mmp is involved
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202674A (en) * 1960-03-05 1965-08-24 American Home Prod Phenethylamine derivatives
US3399211A (en) * 1964-03-10 1968-08-27 Merck & Co Inc Production of 2-aryl-4(5)-nitroimidazoles
NL6816241A (US20100223739A1-20100909-C00005.png) * 1967-12-01 1969-06-03
US3652579A (en) * 1969-06-26 1972-03-28 Hoffmann La Roche 1-methyl-2-substituted 5-nitroimidazoles
NL7017486A (US20100223739A1-20100909-C00005.png) * 1969-12-15 1971-06-17
US3691178A (en) * 1970-03-16 1972-09-12 Merck & Co Inc Substituted imidazoles

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2155558A1 (US20100223739A1-20100909-C00005.png) * 1970-11-16 1972-06-29
US4058614A (en) * 1973-12-04 1977-11-15 Merck & Co., Inc. Substituted imidazole compounds and therapeutic compositions therewith
WO2000018763A2 (en) * 1998-09-29 2000-04-06 Neurogen Corporation 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
WO2000018763A3 (en) * 1998-09-29 2000-05-25 Neurogen Corp 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
US6288230B1 (en) 1998-09-29 2001-09-11 Neurogen Corporation 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
US6432958B1 (en) 1998-09-30 2002-08-13 Neurogen Corporation 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands

Also Published As

Publication number Publication date
NL7017486A (US20100223739A1-20100909-C00005.png) 1971-06-17
FR2081360A1 (US20100223739A1-20100909-C00005.png) 1971-12-03
GB1301754A (US20100223739A1-20100909-C00005.png) 1973-01-04
US4032522A (en) 1977-06-28
US3786061A (en) 1974-01-15
AT300788B (de) 1972-08-10
SE388855B (sv) 1976-10-18
CH566994A5 (US20100223739A1-20100909-C00005.png) 1975-09-30
BE760289A (fr) 1971-06-14
DE2061489C2 (de) 1982-04-01
US4125530A (en) 1978-11-14
DE2061489A1 (de) 1971-07-29
US3818014A (en) 1974-06-18
FR2081360B1 (US20100223739A1-20100909-C00005.png) 1974-08-23
CA945161A (en) 1974-04-09

Similar Documents

Publication Publication Date Title
DE2061515A1 (de) 2,5 disubstituierte Imidazole und Ver fahren zur Herstellung derselben
DE69826127T2 (de) 2-substituierte 4,5-diarylimidazole
DE2147794A1 (de) Neue Triazole und diese enthaltende Zubereitungen
DE2643670C2 (de) 5-Benzyl-4-pyrimidon-Derivate, ihre Salze mit Säuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1795699C3 (US20100223739A1-20100909-C00005.png)
DE2112349A1 (de) Di- und tri-substituierte Imidazole
DE2658267A1 (de) Pyrimid-4-on- und -thion-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD226285A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
CH624938A5 (US20100223739A1-20100909-C00005.png)
DE2847792C2 (US20100223739A1-20100909-C00005.png)
DD149217A5 (de) Verfahren zur herstellung von pyrimidonderivaten
DE2344833A1 (de) Guanidine, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2630060C2 (de) 2-(2-Brom-6-fluor-phenylimino)-imidazolidin, dessen Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
DE2604056A1 (de) Thiocarbaminsaeure-derivate
EP0004561B1 (de) Harnstoff- und Amidoverbindungen, deren Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen und deren Verwendung zur Zubereitung von pharmazeutischen Präparaten
EP0095640A1 (de) Alkylenverbrückte Guanidinothiazolderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE1804306A1 (de) Verfahren zur Herstellung von neuen 2-Cycloalkyl-heteroaryl-Verbindungen
DE2321518C2 (de) Sulfamylbenzoesäuren und deren Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2114607A1 (de) Neue Chinazolinon-Derivate und Verfahren zu ihrer Herstellung
DE2550959C3 (de) Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0094080B1 (de) Pyrido(2,1-b)chinazolinderivate
DD144916A5 (de) Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen
CH638804A5 (de) 1,2,4-triazin-5-on-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DD249479A5 (de) Verfahren zur herstellung von propionamidin-derivaten

Legal Events

Date Code Title Description
OD Request for examination
OHW Rejection